Stay updated on Lintuzumab-Ac225 in Older AML Patients Clinical Trial

Sign up to get notified when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T04:52:41.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page, and the older operating-status notice (Revision: v3.4.1) was removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:28:50.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding status notice and updated the site revision tag to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:44:28.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated QC-related metadata to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older label 'Last Update Submitted that met QC Criteria' and standardizing capitalization such as 'No FEAR Act data' across the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:34:10.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer revision label updated to Revision: v3.3.4; the previous Revision: v3.3.3 label was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:37:25.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Introduced a consolidated 'Locations' section listing study sites by state (California, Kentucky, Louisiana, Minnesota, New York, North Carolina, Pennsylvania, South Carolina, Texas, Washington, West Virginia, Wisconsin) and removed the separate per-state location subsections. Page version updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T20:25:46.000Z thumbnail image

Stay in the know with updates to Lintuzumab-Ac225 in Older AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.